Trevi Therapeutics
$11.94
18
+$0.36+3.11% Thursday 20:00
Statistics
Day High
12.28
Day Low
11.27
52W High
14.39
52W Low
4.85
Volume
1,193,173
Avg. Volume
1,393,111
Mkt Cap
1.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.076667
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-95.82MNet Income
Analyst Ratings
$20.56Average Price Target
The highest estimate is 24.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TRVI. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Biogen
BIIB
Mkt Cap22.63B
Alkermes
ALKS
Mkt Cap5.07B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
AMGEN
AMGN
Mkt Cap160.66B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Jazz Pharmaceuticals
JAZZ
Mkt Cap8.35B
Novartis
NVS
Mkt Cap237.61B
Abbvie
ABBV
Mkt Cap385.18B
About
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Show more...
CEO
Ms. Jennifer L. Good
Employees
31
Country
US
ISIN
US89532M1018
Listings
0 Comments
Share your thoughts
FAQ
What is Trevi Therapeutics stock price today?▼
The current price of TRVI is $11.94 USD — it has increased by +3.11% in the past 24 hours. Watch Trevi Therapeutics stock price performance more closely on the chart.
What is Trevi Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Trevi Therapeutics stocks are traded under the ticker TRVI.
Is Trevi Therapeutics stock price growing?▼
TRVI stock has risen by +5.38% compared to the previous week, the month change is a -8.72% fall, over the last year Trevi Therapeutics has showed a +97.36% increase.
What is Trevi Therapeutics market cap?▼
Today Trevi Therapeutics has the market capitalization of 1.53B
When is the next Trevi Therapeutics earnings date?▼
Trevi Therapeutics is going to release the next earnings report on May 07, 2026.
What were Trevi Therapeutics earnings last quarter?▼
TRVI earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.1 USD resulting in a +37.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Trevi Therapeutics revenue for the last year?▼
Trevi Therapeutics revenue for the last year amounts to 0 USD.
What is Trevi Therapeutics net income for the last year?▼
TRVI net income for the last year is -95.82M USD.
How many employees does Trevi Therapeutics have?▼
As of April 05, 2026, the company has 31 employees.
In which sector is Trevi Therapeutics located?▼
Trevi Therapeutics operates in the Health Care sector.
When did Trevi Therapeutics complete a stock split?▼
Trevi Therapeutics has not had any recent stock splits.
Where is Trevi Therapeutics headquartered?▼
Trevi Therapeutics is headquartered in New Haven, US.